Skip to main content
Caplight Logo









CorNeat Vision

CorNeat Vision

Private
IsraelHealthcare & Life Scienceshttps://www.corneat.com/

Last Round

Grant

Oct 1, 2021

Total Funding Raised

$11.33M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

CorNeat Vision is a healthtech company that develops ophthalmic implants designed for the surgical treatment of corneal blindness and ocular disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

artificial corneakeratoprosthesisbiomimetic implantstissue integrationdonor tissue alternativeophthalmic medical devicecorneal blindnessEverMatrixglaucoma drainage deviceglaucoma shuntsynthetic scleral patchbiomaterial platformocular surface surgerymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CorNeat Vision Comparables

Compare CorNeat Vision with similar companies based on industry and business-model similarity.

CorNeat Vision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EyeYon Medical
89%
BioLattice Ophthalmics, Inc.
87%
KeraMed, Inc.
86%

CorNeat Vision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2021
Early FundingAug 25, 2021

Key People

Founding team and executive leadership

Gilad Litvin

Founder, Chairman, Chief Medical Officer

Founding Team

Eli Aharoni

CTO, VP R&D At Corneat Vision

Executive Team

Tzvika Fisher

Chief Operating Officer

Executive Team

CorNeat Vision Investors

Notable investors and investment history

CorNeat Vision investors
InvestorRounds
European Innovation Council FundGrant
Medical Technology Enterprise ConsortiumGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 42% MoM, reaching 4.1K.

  • Sep 12, 2025

    CorNeat Vision announced unspecified updates for the clinical trial of its CorNeat KPro artificial cornea, including a "groundbreaking clinical achievement" for one of its patients. The article does not provide details on the updates or the achievement.

CorNeat Vision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CorNeat Vision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CorNeat Vision's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range15
Year Founded2015
Last FundingOct 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?